Dr. Dick Nathan Einerson, DMD Dentist Medicare: Medicare Enrolled Practice Location: East Hwy 262, Montezuma Creek, UT 84511 Phone: 435-651-3700 |
Hal Bawden Dentist Medicare: Medicare Enrolled Practice Location: East Highway 262, Montezuma Creek, UT 84534 Phone: 435-651-3700 Fax: 435-651-3376 |
Dr. Vance Robert Telford, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: East Highway 262, Montezuma Creek, UT 84534 Phone: 435-678-0564 |
Crystal Sekaquaptewa, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: East Highway 262, Montezuma Creek, UT 84534 Phone: 435-651-3700 Fax: 435-651-3376 |
Dr. Brian F Olsen, D.D.S Dentist - General Practice Medicare: Medicare Enrolled Practice Location: East Hwy 262, Unhs Dental, Montezuma Creek, UT 84534 Phone: 435-485-0121 Fax: 866-275-2831 |
Joseph D Vreeken, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: East Highway 262, Montezuma Creek, UT 84534 Phone: 435-651-3291 Fax: 435-651-3376 |
News Archive
Today the U.S. Department of Health and Human Services released the first in a series of web videos and public service announcements to promote First Lady Michelle Obama's national initiative, Let's Move, to solve childhood obesity within a generation. Childhood obesity and excess weight threatens the healthy future of one third of American children.
Longitudinal monitoring of 30 tests for marker candidates in early Parkinson's disease has found that just 10 show significant changes commensurate with disease progression.
Pulmonary function test results (PFTs) in patients treated with AFREZZATM (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, ultra rapid acting insulin, at follow-up measurements were similar to PFT results observed in patients receiving standard antidiabetic therapy, according to data presented today at the American Association of Clinical Endocrinologists 19th Annual Meeting (Poster #267).
DNAstack, a Toronto based company, today is announcing the investment into its cloud-based genomics software platform from the National Research Council of Canada Industrial Research Assistance Program.
The use of hypofractionated whole-breast irradiation (HF-WBI) for patients with early-stage breast cancer increased 17.4 percent from 2004 to 2011, and patients are more likely to receive HF-WBI compared to conventionally fractionated whole-breast irradiation (CF-WBI) when they are treated at an academic center or live ≥50 miles away from a cancer center, according to a study published in the December 1, 2014 issue of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology.
› Verified 3 days ago